Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

OBJECTIVES: To evaluate the safety and efficacy of 5-year, long-term tocilizumab monotherapy for patients with rheumatoid arthritis. METHODS: In an open-label, long-term extension trial following an initial 3-month randomised phase II trial, 143 of the 163 patients who participated in the initial bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, N, Miyasaka, N, Yamamoto, K, Kawai, S, Takeuchi, T, Azuma, J
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732899/
https://www.ncbi.nlm.nih.gov/pubmed/19019888
http://dx.doi.org/10.1136/ard.2008.092866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732899/
https://www.ncbi.nlm.nih.gov/pubmed/19019888
http://dx.doi.org/10.1136/ard.2008.092866

Ejemplares similares